Unknown

Dataset Information

0

Improving outcomes for brain metastases in EGFR mutated NSCLC.

ABSTRACT:

SUBMITTER: Carlisle JW 

PROVIDER: S-EPMC6987335 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Improving outcomes for brain metastases in EGFR mutated NSCLC.

Carlisle Jennifer W JW   Ramalingam Suresh S SS  

Translational lung cancer research 20191201 Suppl 4

Similar Datasets

Unknown Efficacy of dacomitinib in patients with EGFR-mutated NSCLC and brain metastases.
| S-EPMC8671892 | biostudies-literature
Unknown Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases.
| S-EPMC10527103 | biostudies-literature
Unknown Comparison of the Efficacy of Different First-Line Therapies for EGFR L858R-Mutated NSCLC Patients With Brain Metastases.
| S-EPMC12580884 | biostudies-literature
Unknown Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
| S-EPMC9150343 | biostudies-literature
Unknown Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced <i>EGFR</i>-Mutated NSCLC.
| S-EPMC10973185 | biostudies-literature
Unknown Osimertinib in combination with bevacizumab in <i>EGFR</i>-Mutated NSCLC with leptomeningeal metastases.
| S-EPMC7815344 | biostudies-literature
Unknown A Podcast Discussion on the Intracranial Efficacy of Antibody-Drug Conjugates in Patients with EGFR-Mutated NSCLC with Brain Metastases.
| S-EPMC11880489 | biostudies-literature
Unknown Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer.
| S-EPMC8182502 | biostudies-literature
Unknown Cost-effectiveness analysis of first-line gifitinib plus pemetrexed-platinum-based chemotherapy versus gifitinib monotherapy in EGFR-mutated NSCLC patients with brain metastases
| S-EPMC12382008 | biostudies-literature
Unknown Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients.
| S-EPMC12362994 | biostudies-literature